Literature DB >> 17891543

An 8-year-old boy with autoimmune hepatitis and Candida onychosis as the first symptoms of autoimmune polyglandular syndrome (APS1): identification of a new homozygous mutation in the autoimmune regulator gene (AIRE).

Carla Lintas1, Marco Cappa, Donatella Comparcola, Valerio Nobili, Alessandra Fierabracci.   

Abstract

An 8-year-old boy presented in 1995 with a 2-year history of hypertransaminasemia and hypergammaglobulinemia. Afterwards the patient displayed onychosis with a positive culture test for Candida albicans (CA). Because of the persistence of hypertransaminasemia, a percutaneous liver biopsy was performed showing 'low grade chronic active autoimmune hepatitis' (AIH), positive for liver-kidney microsomal autoantibodies and antibodies to the hepatic autoantigen cytochrome P450-1A2. Immunosuppressive treatment was initiated. In 2003 he developed Addison's disease resulting in the diagnosis of autoimmune polyendocrinopathy candidiasis-ectodermal dysplasia (APECED) syndrome, also known as autoimmune polyendocrine syndrome type 1 (APS1). Anti-17OH hydroxylase antibodies tested negative, anti-21-OH hydroxylase autoantibodies were positive. Among the other relevant organ- and non organ- specific autoantibodies, aromatic L-amino acid decarboxylase (ADDC) autoantibodies and anti-tryptophan hydroxylase autoantibodies were positive. The patient also presented polyuria and polydypsia with diabetes insipidus. Because of the presence of two diagnostic criteria of APS1, mutations in the autoimmune regulator gene (AIRE) were performed, which revealed the presence of a novel mutation (c1314- 1326 del 13/insGT) in exon 11. In conclusion, the diagnosis of APECED should be suspected in any child with minimal hypertransaminasemia, anti-microsomal autoantibodies and Candida albicans onychosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17891543     DOI: 10.1007/s00431-007-0599-4

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  6 in total

1.  A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Authors:  Eliisa Kekäläinen; Heli Tuovinen; Joonas Joensuu; Mikhail Gylling; Rauli Franssila; Nora Pöntynen; Kimmo Talvensaari; Jaakko Perheentupa; Aaro Miettinen; T Petteri Arstila
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

2.  CD4+ CD25+ regulatory T cells control the magnitude of T-dependent humoral immune responses to exogenous antigens.

Authors:  Fouad Eddahri; Guillaume Oldenhove; Sébastien Denanglaire; Jacques Urbain; Oberdan Leo; Fabienne Andris
Journal:  Eur J Immunol       Date:  2006-04       Impact factor: 5.532

3.  Autoimmune regulator (AIRE) gene is expressed in human activated CD4+ T-cells and regulated by mitogen-activated protein kinase pathway.

Authors:  Seiho Nagafuchi; Hitoshi Katsuta; Rimiko Koyanagi-Katsuta; Satoshi Yamasaki; Yasushi Inoue; Kazuya Shimoda; Yukari Ikeda; Mieko Shindo; Eiko Yoshida; Tomohito Matsuo; Yuju Ohno; Kazuhiko Kogawa; Keizo Anzai; Hironori Kurisaki; Jun Kudoh; Mine Harada; Nobuyoshi Shimizu
Journal:  Microbiol Immunol       Date:  2006       Impact factor: 1.955

4.  Detection of autoimmune regulator gene mutations in children with type 2 autoimmune hepatitis and extrahepatic immune-mediated diseases.

Authors:  Tim O Lankisch; Christian P Strassburg; Dominique Debray; Michael P Manns; Emmanuel Jacquemin
Journal:  J Pediatr       Date:  2005-06       Impact factor: 4.406

5.  Autoimmune regulator AIRE: evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1.

Authors:  A Vogel; H Liermann; A Harms; C P Strassburg; M P Manns; P Obermayer-Straub
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

6.  Defective regulatory and effector T cell functions in patients with FOXP3 mutations.

Authors:  Rosa Bacchetta; Laura Passerini; Eleonora Gambineri; Minyue Dai; Sarah E Allan; Lucia Perroni; Franca Dagna-Bricarelli; Claudia Sartirana; Susanne Matthes-Martin; Anita Lawitschka; Chiara Azzari; Steven F Ziegler; Megan K Levings; Maria Grazia Roncarolo
Journal:  J Clin Invest       Date:  2006-06       Impact factor: 14.808

  6 in total
  5 in total

1.  Hypoparathyroidism and central diabetes insipidus: in search of the link.

Authors:  Ori Eyal; Asaf Oren; Harald Jüppner; Raz Somech; Annamaria De Bellis; Michael Mannstadt; Auryan Szalat; Margalit Bleiberg; Yosef Weisman; Naomi Weintrob
Journal:  Eur J Pediatr       Date:  2014-11-04       Impact factor: 3.183

2.  Molecular background and genotype-phenotype correlation in autoimmune-polyendocrinopathy-candidiasis-ectodermal-distrophy patients from Campania and in their relatives.

Authors:  D Capalbo; C Mazza; R Giordano; N Improda; E Arvat; S Cervato; L Morlin; C Pignata; C Betterle; M Salerno
Journal:  J Endocrinol Invest       Date:  2011-04-20       Impact factor: 4.256

3.  Sicilian family with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and lethal lung disease in one of the affected brothers.

Authors:  Filippo De Luca; Mariella Valenzise; Rita Alaggio; Teresa Arrigo; Giuseppe Crisafulli; Giuseppina Salzano; Sara Cervato; Barbara Mariniello; Francesca Lazzarotto; Corrado Betterle
Journal:  Eur J Pediatr       Date:  2008-02-15       Impact factor: 3.183

4.  Autoantibodies against CYP-2C19: A Novel Serum Marker in Pediatric De Novo Autoimmune Hepatitis?

Authors:  Maria Grazia Clemente; Roberto Antonucci; Claudia Mandato; Lucia Cicotto; Antonella Meloni; Bruno Gridelli; Stefano De Virgiliis; Michael P Manns; Pietro Vajro
Journal:  Biomed Res Int       Date:  2017-11-27       Impact factor: 3.411

5.  Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients.

Authors:  S Garelli; M Dalla Costa; C Sabbadin; S Barollo; B Rubin; R Scarpa; S Masiero; A Fierabracci; C Bizzarri; A Crinò; M Cappa; M Valenzise; A Meloni; A M De Bellis; C Giordano; F Presotto; R Perniola; D Capalbo; M C Salerno; A Stigliano; G Radetti; V Camozzi; N A Greggio; F Bogazzi; I Chiodini; U Pagotto; S K Black; S Chen; B Rees Smith; J Furmaniak; G Weber; F Pigliaru; L De Sanctis; C Scaroni; C Betterle
Journal:  J Endocrinol Invest       Date:  2021-05-18       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.